Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Safety and Toxicity Trial of Adjuvant Chemotherapy With Gemcitabine and Docetaxel and Radiation Therapy for Completely Resected Uterine Leiomyosarcoma

NCT01958580 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.

NCT NCT01958580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01958580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Safety and Toxicity Trial of Adjuvant Chemotherapy With Gemcitabine and Docetaxel and Radiation Therapy for Completely Resected Uterine Leiomyosarcoma
Lead sponsor
Albert Einstein College of Medicine
Phase
Not applicable
Overall status
Terminated
Start date
September 17, 2013
Completion date
February 24, 2017
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia uterine sarcoma, stage ib uterine sarcoma, stage ic uterine sarcoma, stage iia uterine sarcoma, stage iib uterine sarcoma, stage iiia uterine sarcoma, stage iiib uterine sarcoma, stage iiic uterine sarcoma, stage iva uterine sarcoma, stage ivb uterine sarcoma, uterine corpus leiomyosarcoma